Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting.

Silvia Canivell Manel Mata-CasesJordi RealJosep Franch-NadalBogdan VlachoKamlesh Khunti F MedSciMònica GratacòsEsmeralda Castelblanco

Published in: Diabetes, obesity & metabolism (2019)

Despite intensification, most patients failed the glycaemic goal of HbA1c <7%. The reduction depended mainly on preintensification HbA1c values, with small differences between drugs.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes
adipose tissue
metabolic syndrome
skeletal muscle
insulin resistance
drug induced
patient reported
weight loss